Apcotex Industries Limited Overview
Apcotex Industries is India's leading and, in several chemistries, only domestic producer of emulsion-polymerised synthetic rubber and synthetic latex. It is the sole Indian manufacturer of nitrile butadiene rubber (NBR), high styrene rubber (HSR) and nitrile latex (company factsheet, Q1 FY2027; Indian Chemical News interview).
The company runs two integrated plants: Taloja in Maharashtra and Valia in Gujarat. Its products serve tyre-cord dipping, paper and paperboard coating, carpets, textiles, construction and waterproofing, nitrile gloves, footwear, automotive rubber goods, hoses, brake pads and conveyor belts.
The company was spun out of Asian Paints and is controlled by the Choksey family. It combines a high-entry-barrier technology base with long customer qualification cycles. That position has been reinforced by trade-remedy action against dumped NBR imports.
After a two-year margin trough in FY2024–FY2025, profitability recovered sharply in FY2026 and reached a record in Q1 FY2027. A ₹210–220 Cr Valia expansion, now targeted for Q1 FY2028, is management's main growth lever.
Company's own description
In its Q1 FY2027 earnings presentation and factsheet, Apcotex describes itself as follows:
-
A leading Indian producer of synthetic rubber (nitrile rubber, high styrene rubber, nitrile polyblends and nitrile powder) and synthetic latex (XSB latex, VP latex, styrene acrylics and nitrile latex).
-
A company with a broad range of emulsion polymers, integrated manufacturing at Taloja and Valia, strong in-house R&D for specialty product development and customisation, and high entry barriers from complex technology, large capital requirements and long customer qualification.
The company states in its statutory results that it operates in one business segment: synthetic emulsion polymers.
Independent characterisation
Apcotex is a mid-cap Indian specialty chemicals company with an intermediate (B2B) position in the value chain.
Inputs. Its main raw materials are petrochemical monomers: butadiene, styrene, acrylonitrile and acrylic monomers. Their prices follow crude oil and Asian petrochemical cycles.
Outputs. It converts these monomers through emulsion polymerisation into two families of products:
-
Water-based dispersions (latices), sold to industrial converters such as tyre-cord dippers, paper mills, carpet makers, glove makers and construction-chemical formulators.
-
Solid rubbers (NBR bales, HSR, NBR/PVC polyblends, NBR powder), sold to rubber-goods compounders: automotive seals and hoses, footwear, brake pads, rice dehusking rollers and conveyor belts.
Revenue model. Revenue is almost entirely product sales, priced on a cost-plus or spread basis over monomer costs. There is no meaningful service, subscription or licensing income.
Margin dynamics. Because pricing follows raw materials with a lag, reported revenue can fall even when volumes rise. For example, Q3 FY2026 revenue fell 7% on 10% volume growth (Q3 FY2026 call transcript). Margins expand when inventory is bought low and sold high, as in Q1 FY2027, where inventory gains added about 2 percentage points to EBITDA margin.
Customer types. Large Indian and multinational industrial customers. Disclosed marquee names include MRF, SRF, Century Enka, Armacell and Supreme Industries (company presentations).
Geographic mix. Exports are a material and growing share of the business. Export volumes rose 31% year-on-year in H1 FY2026 and reached a record in FY2026.
End-markets served
| End-market | Products used | Demand driver |
|---|---|---|
| Tyres (tyre-cord dipping) | VP (vinyl pyridine) latex | Tyre production and replacement demand |
| Paper & paperboard | Carboxylated SB (XSB) latex | Packaging and coated board demand |
| Carpets & textiles | XSB / SB latex | Carpet backing, textile finishing, exports |
| Construction & waterproofing | Styrene-acrylic, SB latex (incl. ApcoBuild range) | Housing and infrastructure |
| Nonwovens & adhesives | Specialty binders | Hygiene and industrial nonwovens |
| Gloves (medical/industrial) | Nitrile latex | Healthcare and industrial safety |
| Automotive & industrial rubber goods | NBR, NBR polyblends | Vehicle production, oil seals, hoses, gaskets |
| Footwear | HSR | Footwear soling |
| Friction materials | NBR powder | Brake pads |
| Agriculture processing | NBR compounds | Rice dehusking rollers |
Strategy
Stated strategic themes
These are paraphrased from company presentations, factsheets and earnings calls in FY2026–FY2027:
-
Capacity-led volume growth in NBR and synthetic latex, where existing lines are at or near optimal utilisation, to meet domestic and international demand.
-
Product-portfolio broadening in specialty emulsions, adding newer grades and products every year (2023 interview). The factsheet also refers to expansion beyond the existing product portfolio.
-
Export expansion. The company has highlighted export volume records repeatedly since FY2025.
-
Strengthening presence in carpet, paper, construction and glove end-markets through the new latex capacity (factsheet).
-
Cost and operating excellence through TPM, utilisation improvement and debt reduction to net cash.
-
Sustainability and green power, via minority equity stakes in solar and wind SPVs.
-
Trade-defence advocacy to secure a level playing field in NBR.
Initiatives in the last 24 months
| Date | Initiative | Detail |
|---|---|---|
| Sep 2024 → Sep 2025 | NBR anti-dumping petition | DGTR final findings recommend USD 205–606/t duties on certain exporters. Notification status by the Finance Ministry is unclear (see Section 19). |
| Nov 2025 | Valia expansion | ₹210 Cr; +37,000 MTPA synthetic latex and +14,600 MTPA NBR and allied products. Funded by internal accruals and debt. Originally due Q1 FY2027. |
| Feb 2026 | Capex efficiency | The investor presentation (per ScanX) cites one expansion element at ₹130–140 Cr, versus ₹200–250 Cr originally envisaged, through innovative debottlenecking. It is not clear which project this refers to. |
| 27 Mar 2026 | Renewable power | ₹72 lakh for 2.55% of Amplus Ceres Solar and ₹1.32 Cr for 2.14% of Amplus Energy One, with power purchase agreements |
| 2,026 | Wind/hybrid power | 5.12% stake in Opera Vayu (Narmada) |
| Jul 2026 | Revised capex timing | NBR expansion on stream by Q1 FY2028, latex shortly after. Total project about ₹220 Cr; revenue potential about ₹600 Cr per year at full utilisation. |
Management guidance (Q1 FY2027 call, 30 July 2026)
-
Medium-term average EBITDA margin of 15–16%. Management acknowledged that the Q1 FY2027 level of 22.3% is unusually high.
-
Double-digit volume growth in FY2027, possibly low double digits, if demand holds and capacity is available.
-
Capex of about INR 650 Mn in the year, of which INR 200–250 Mn is for expansion projects; the balance spills into FY2028.
-
About ₹600 Cr of incremental annual revenue potential once the new capacities ramp up.
Products & Services
Product details are drawn from the company factsheet (Q1 FY2027), company presentations, the ROIC.ai company description and the Indian Chemical News interview. The company does not disclose pricing; all products are sold on negotiated, raw-material-linked B2B pricing.
Synthetic Latex
Vinyl Pyridine (VP) Latex
-
Description: Terpolymer latex used in RFL (resorcinol-formaldehyde-latex) dips that bond tyre cord (nylon, polyester, rayon) to rubber.
-
Capabilities: Adhesion promotion for reinforced rubber.
-
Target customers: Tyre makers and tyre-cord fabric producers. Century Enka and SRF are disclosed customers.
-
History: The company describes itself as India's first VP latex producer.
Carboxylated Styrene-Butadiene (XSB) Latex
-
Description: Binder for pigment coatings on paper and paperboard; also used as a carpet-backing binder.
-
Target customers: Paper and board mills; carpet makers.
-
History: The company describes itself as India's first XSB latex producer.
Styrene-Butadiene (SB / SBR) Latex
-
Description: General-purpose latex for carpets, textiles and construction modifiers.
-
Target customers: Carpet and textile processors; construction chemicals makers.
Styrene-Acrylic and Pure Acrylic Latices
-
Description: Binders for construction chemicals, waterproofing, paints and coatings, adhesives and nonwovens.
-
Target customers: Construction-chemical formulators and coatings companies.
-
Brand: ApcoBuild, a construction and waterproofing latex range referenced on the Q4 FY2023 earnings call.
Vinyl Acetate–based emulsions
-
Description: Adhesives and specialty binders.
-
History: Produced from the multi-purpose emulsions plant at Taloja (investment made in FY2023).
Specialty binders for nonwovens and adhesives
- Description: Binders for hygiene and industrial nonwovens and for pressure-sensitive or laminating adhesives.
Nitrile Latex (NBR Latex)
-
Description: Carboxylated nitrile latex for dipped goods, mainly nitrile examination and industrial gloves.
-
Capacity: 50,000 MTPA at Valia.
-
Target customers: Glove manufacturers in India and abroad.
-
History: India's first nitrile latex plant, built as part of the FY2023 investment programme. The company is the only Indian producer.
Latex for fabric dipping (tyre cord) and other specialty applications
- Description: Specialty latex grades listed in the factsheet beyond the core families above.
Synthetic Rubber
Nitrile Butadiene Rubber (NBR), solid bales
-
Description: Oil-, fuel- and heat-resistant elastomer with acrylonitrile content typically 25–42% in the grades covered by trade remedies.
-
Applications: Oil seals, O-rings, gaskets, fuel and oil hoses, rubber rollers, conveyor belts, rice dehusking rollers. The factsheet notes good processability and tack for moulded and extruded goods.
-
Target customers: Automotive component makers and industrial rubber-goods compounders.
-
Position: Sole Indian manufacturer. Management said NBR sales roughly tripled over six years from the same plant (2023 interview), and the solid NBR line ran at full capacity throughout FY2026 (February 2026 presentation, per ScanX).
NBR Polyblends (NBR/PVC)
-
Description: Blends of NBR and PVC that improve ozone and weather resistance at lower cost.
-
Applications: Automotive hoses and cable jackets. The factsheet describes it as a cost-effective solution for automotive uses.
NBR Powder
-
Description: Pre-crosslinked or powdered NBR.
-
Applications: Friction materials (brake pads), PVC modification.
High Styrene Rubber (HSR)
-
Description: Reinforcing styrene-butadiene resin used with SBR or natural rubber.
-
Capacity: 7,000 MTPA (Taloja).
-
Applications: Footwear soling and microcellular sheets.
-
Position: Sole Indian manufacturer (factsheet).
Services
Apcotex provides technical service and application support, including custom grade development, as part of the product sale. No separately priced service lines exist.
Financial Detail
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Synthetic Emulsion Polymers segment revenue (INR Mn) | 11,246 | 13,924 | 14,415 |
Segment EBITDA (INR Mn) | 1,139 | 1,247 | 1,774 |
Segment EBITDA margin (%) | 10.13 | 8.96 | 12.31 |
Segment revenue YoY growth (%) | 4.1 | 23.8 | 3.5 |
Share of total revenue (%) | 100 | 100 | 100 |
Product Families
| Product family | Contents | Plant | Installed capacity (MTPA) |
|---|---|---|---|
Synthetic latex | VP latex, XSB/SB latex, styrene-acrylic, acrylic, vinyl acetate, specialty binders | Taloja | 103,000 |
Nitrile latex | Nitrile latex for gloves | Valia | 50,000 |
Synthetic rubber – NBR & allied | NBR bales, NBR polyblends, NBR powder | Valia | 21,000 |
Synthetic rubber – HSR | High styrene rubber | Taloja | 7,000 |
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Mn) | 9,569 | 10,799 | 11,246 | 13,924 | 14,415 |
Revenue YoY growth (%) | 77.0 | 12.9 | 4.1 | 23.8 | 3.5 |
Operating EBITDA (INR Mn) | 1,398 | 1,585 | 1,139 | 1,247 | 1,774 |
EBITDA margin (%) | 14.61 | 14.68 | 10.13 | 8.96 | 12.31 |
Net profit / PAT (INR Mn) | 988 | 1,079 | 539 | 541 | 1,014 |
Net profit margin (%) | 10.33 | 9.99 | 4.79 | 3.89 | 7.03 |
EPS basic (INR) | 19.06 | 20.82 | 10.39 | 10.43 | 19.56 |
Dividend per share (INR) | 5.0 | 5.5 | 5.5 | 6.5 | 8.0 |
Dividend payout ratio (%) | 26.2 | 26.4 | 52.9 | 62.3 | 40.9 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement
| Item | FY2024 | FY2025 | FY2026 | Source |
|---|---|---|---|---|
Profit before tax (INR Mn) | — | 762.5 | 1,348.5 | FY2026 results (5paisa summary of filing) |
Other income (INR Mn) | 77.2 | 103.8 | — | FY2025 directors' report |
Exceptional items (INR Mn) | Nil | Nil | +57.5 gain on sale of office; −47.8 labour-code employee benefit charge | FY2026 results notes |
Gross profit / gross margin | Not publicly disclosed in a comparable format | — | — | Raw material cost is disclosed quarterly but not compiled here |
Operating income (EBIT) | Not publicly disclosed separately | — | — | EBIT ≈ EBITDA less depreciation. Q3 FY2026 quarterly depreciation was INR 123 Mn. |
Income Statement and Margin Analysis (%) (Quarterly)
| Metric | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|
Revenue from operations (INR Mn) | 3,758 | 3,367 | 3,315 | 3,976 | 5,256 |
Operating EBITDA (INR Mn) | 387 | 406 | 435 | 546 | 1,171 |
EBITDA margin (%) | 10.30 | 12.06 | 13.12 | 13.75 | 22.28 |
PBT (INR Mn) | 263 | 330 | 275 | 450 | 1,046 |
PAT (INR Mn) | 192 | 253 | 222 | 347 | 789 |
Diluted EPS (INR) | 3.70 | 4.88 | 4.29 | 6.70 | 15.23 |
Financial Analysis
| Item | Data point | Source |
|---|---|---|
Net cash / (net debt), 31 Mar 2026 | Net cash of about INR 700 Mn (cash and investments exceed borrowings) | FY2026 results release (FilingReader) |
Net cash status, 30 Sep 2025 / 31 Dec 2025 | Net cash positive | Q2 and Q3 FY2026 presentations |
Debt reduction | About ₹53 Cr repaid in H1 FY2026; about ₹94 Cr over 9M FY2026 | Q2 and Q3 FY2026 presentations |
Capital work in progress | FY2021: 116; FY2022: 386; FY2023: 123; H1 FY2024: 100 (INR Mn) | Company presentations FY2024 |
Total equity / book value | Aggregators conflict. BV/share of INR 95.28 (Business Standard, FY2025 basis) implies equity of about INR 4,940 Mn. P/B of 5.08–5.33 at INR 608–611 (Anand Rathi, IIFL, mid-2026) implies BV/share of about INR 115, i.e., equity of about INR 5,950 Mn after FY2026. One source shows P/B 2.62, which is inconsistent and disregarded. | Flagged discrepancy |
Goodwill & intangibles | Not publicly disclosed in retrieved data. Expected to be small; the 2016 Valia acquisition may carry some intangibles. | — |
Total assets, working capital, debt split (short/long) | Not publicly disclosed in retrieved data | — |
Working capital trend | Rose in Q1 FY2027 because of higher raw material prices and inventory values | Q1 FY2027 call (Quartr; Kalkine) |
Cash Flow
| Metric | FY2025 | FY2026 |
|---|---|---|
Net cash from operating activities (INR Mn) | 847.2 | 2,034.4 |
Dividends declared for the year (INR Mn, approx.) | 337 | 415 |
Financial Analysis — ROE FY2026
| Ratio | Value | Basis |
|---|---|---|
ROE FY2026 | About 16–17% | 5paisa states ROE of 16%. Computed: 1,014 / average equity of about 5,450 Mn ≈ 18.6%. |
ROE FY2023 (peak) | Not publicly disclosed in retrieved data | — |
Net debt / EBITDA FY2026 | Negative (net cash ≈ −0.4x) | Computed: −700 / 1,774 |
Debt/equity | Low; net cash positive | — |
Interest coverage | High. Q1 FY2027 finance cost was INR 22 Mn against INR 1,171 Mn of EBITDA (~53x). | AskFuzz summary of Q1 FY2027 filing |
ROA, ROIC, current ratio, asset turnover, cash conversion cycle | Not publicly disclosed in retrieved data | — |
Revenue History
| Period | Total sales volume YoY | Export volume YoY | Domestic volume YoY | Source |
|---|---|---|---|---|
Q1 FY2025 | +14% | Record exports | — | Quartr summary |
H1 FY2026 | +18% (record) | +31% (record) | — | Q2 FY2026 presentation |
Q2 FY2026 | +11% | — | — | Q2 FY2026 presentation |
Q3 FY2026 | +10% | Record | — | Q3 FY2026 call |
FY2026 | +14% (record) | +14% (record) | — | FY2026 results release |
Q1 FY2027 | −10% to −12% | Sharply down (West Asia logistics disruption) | +10% | Q1 FY2027 call |
Valuation Snapshot
| Metric | Value | Source / date |
|---|---|---|
Current price | INR 603.25 | Trendlyne, 14 Oct 2026 |
52-week high / low | INR 712.45 / INR 310.15 | Anand Rathi, Sep 2026 |
1-year return | About +50% | Anand Rathi, 22 Sep 2026 |
6-month return | About +76% | Anand Rathi, 22 Sep 2026 |
3-year return | About +18% to +21% | Anand Rathi, Aug–Sep 2026 |
Capital Markets Data (INR) and Market Valuation
| Metric | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|
Month-end close (INR) | 400.55 | 395.65 | 373.85 | 313.95 |
Market cap (INR Cr) | 2,076.65 | 2,051.25 | 1,938.22 | 1,627.67 |
Valuation Snapshot by Multiple
| Multiple | Value | Basis |
|---|---|---|
P/E (TTM) | About 19.4x | TTM EPS INR 31.08 (Investing.com; matches computed 1,014 + 789 − 192 = 1,611 Mn) |
P/E (FY2026) | About 30.8x | FY2026 EPS INR 19.56 |
EV/EBITDA (TTM) | About 12.0x | EV ≈ 31,275 − 700 net cash = 30,575 Mn; TTM EBITDA ≈ 2,558 Mn |
EV/Sales (TTM) | About 1.9x | TTM revenue ≈ 15,913 Mn |
P/B | About 5.1x | Anand Rathi / IIFL (Aug 2026). |
Dividend yield | About 1.3% | INR 8.0 / INR 603 |
Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share (INR) | 5.0 | 5.5 | 5.5 | 6.5 | 8.0 |
Analyst Conclusions
Management guidance (Q1 FY2027 call, 30 July 2026)
-
Medium-term EBITDA margin of 15–16%.
-
Double-digit (likely low double-digit) volume growth in FY2027, subject to demand and capacity.
-
Annual capex of about INR 650 Mn.
-
NBR expansion on stream in Q1 FY2028, with latex additions shortly after.
-
About ₹600 Cr of incremental revenue potential from the expansion.
Consensus
The single published target of INR 700 implies about 16% upside from INR 603.
Bull case
-
Capacity unlock. About 51,600 MTPA of new latex and NBR capacity, against fully utilised NBR lines, supports about ₹600 Cr of revenue, roughly 40% of FY2026 revenue, from FY2028.
-
Structural margin uplift. FY2026's 12.3% EBITDA margin was achieved without trade-remedy duties. Notified duties plus operating leverage could hold margins at the upper end of the 15–16% guidance.
-
Cash generation and balance sheet. INR 2,034 Mn of FY2026 OCF and a net cash position fund capex mostly internally while supporting rising dividends (INR 8.0 in FY2026, the highest on record).
Bear case
-
Q1 FY2027 was cyclical. About 2 percentage points of the margin came from inventory gains, and volumes fell 10–12%. Margin normalisation to 15–16% implies sequential earnings declines.
-
Trade policy may disappoint. The 2021 rejection precedent, and zero-duty treatment for major exporters (Arlanxeo France, Kumho, Sibur), limit any benefit.
-
Execution and demand risk. The expansion has already slipped a year. Export markets face geopolitical disruption, and glove and automotive demand is cyclical.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing |
|---|---|
| Q2 FY2027 results: margin normalisation and export recovery | ~22 Oct 2026 (expected) |
| Finance Ministry notification on NBR anti-dumping duty | Uncertain |
| Valia expansion construction milestones | Through FY2027; commissioning Q1 FY2028 |
| Raw-material spreads (butadiene, ACN, styrene) | Ongoing |
| Normalisation of West Asia logistics | Ongoing |
| Interim dividend | Jan–Feb 2027 |
| FY2027 results and final dividend | ~May 2027 |
| Working-capital trajectory | Quarterly |
Analyst verdict
Apcotex Industries has moved from a two-year margin trough to record profitability in roughly eighteen months. The recovery rests on real operating progress: volumes have reached records, utilisation has improved, debt has been repaid, and operating cash flow more than doubled. It is not simply a price story.
The company's strategic position is distinctive and hard to replicate. It is the only Indian producer of NBR, HSR and nitrile latex, it has a five-decade lineage from Asian Paints, and its customers include tyre, rubber-goods and construction leaders whose qualification processes create switching costs. Its net cash balance sheet gives it flexibility that few small-cap chemical companies have.
The Q1 FY2027 numbers, however, should not be extrapolated. A 22.3% EBITDA margin on falling volumes, including inventory gains, is a cyclical high. Management's own 15–16% medium-term guidance is the right anchor.
At about 19x trailing earnings and about 12x trailing EV/EBITDA, the stock already prices in much of the normalised recovery. On FY2026 earnings it trades at about 31x. Upside depends on two binary items: commissioning of the Valia expansion in Q1 FY2028, which offers about 40% revenue capacity growth, and eventual notification of NBR anti-dumping duties, where history counsels caution.
Our synthesis is constructive on the business but neutral to cautiously positive on near-term valuation. Through FY2027, earnings are likely to decline sequentially from the Q1 peak as margins normalise and the new capacity is not yet online. The more compelling earnings step-up comes in FY2028–FY2029, once new capacity reaches customers. Investors should watch quarterly EBITDA per tonne, export volume recovery, working-capital discipline and the expansion timeline as the key evidence points. Promoter alignment (58% ownership, no pledge) and the dividend record lower governance risk. Thin institutional ownership and limited segment disclosure remain constraints on valuation re-rating.
Source notes
Primary sources:
-
NSE/BSE exchange filings: results, integrated filings, prior intimations, Reg. 30 disclosures.
-
Company earnings presentations (Q1 FY2024, Q3 FY2024, Q2 FY2026, Q3 FY2026, Q1 FY2027) and factsheets prepared via Valorem Advisors.
-
Earnings call transcripts (Q4 FY2023, Q2 FY2026, Q3 FY2026, Q1 FY2027).
-
Directors' Report FY2025.
Secondary sources:
-
FilingReader, Capital Market (via JM Financial and Business Standard), Kalkine, Quartr, ScanX, DSIJ, 5paisa, Trendlyne, Simply Wall St, Investing.com, TradingView, Anand Rathi, IIFL, Arihant Capital/CMOTS.
-
European Rubber Journal and ICIS on trade remedies.
-
Indian Chemical News on management interviews.
-
ICICI Direct (2020 result update).
Where secondary sources conflict (P/B, total revenue including other income, capacity locations), the discrepancy is noted in the relevant section and company-reported figures are preferred.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure / background | Source |
|---|---|---|---|
Atul C. Choksey | Non-Executive, Non-Independent Chairman | Former MD of Asian Paints; promoter. Re-appointed at the 40th AGM (25 Jun 2026). Holds about 13.3%. | Q1 FY2027 presentation; ScanX AGM summary; Simply Wall St |
Abhiraj A. Choksey | Vice Chairman & Managing Director | Joined 2005; MD since May 2010; re-appointed in 2022 (and subsequently; title is now VC & MD). Engineering and business degrees (Wharton) from the University of Pennsylvania; earlier US strategy consulting and IT. Member of the Indian Chemical Council Executive Committee, YPO and EO. Holds about 14.3%. | Indian Chemical News, Mar 2022; Q1 FY2027 call invite |
Amit C. Choksey | Non-Executive Director (promoter family) | Re-appointed as director at the 40th AGM | ScanX AGM summary |
Ravishankar Sharma | Executive Director (Whole-time) | Re-appointed as Executive Director (2026) | ScanX news feed |
Vivek Thakur | Chief Financial Officer | Appointed 2025, succeeding Sachin Karwa | Quartr; Q1 FY2027 call invite |
Drigesh Mittal | Head – Company Secretary & Legal | Compliance officer | FilingReader, Nov 2025 |
Udayan Choksi | Independent Director | Second five-year term to 28 Jul 2029 | Board outcome, 17 Jun 2024 |
Dinanath Kholkar | Independent Director | Appointed 17 Jun 2024 for five years | Board outcome, 17 Jun 2024 |
Dr. Achala Danait | Independent Director | Appointed 26 Jul 2023 | NSE filing, 26 Jul 2023 |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
26 Jul 2023 | Dr. Achala Danait joins as Independent Director | Board refresh |
17 Jun 2024 | Dinanath Kholkar joins as Independent Director; Udayan Choksi re-appointed | Board refresh |
26 Mar 2025 | CFO Sachin Karwa resigns | He later joined Sutlej Textiles as CFO; stock −3% on the day |
| 2025 | Vivek Thakur appointed CFO | Succession |
27 Mar 2026 | "Change in management" filing alongside the solar investments | Re-appointment(s); ScanX references a director re-appointment |
25 Jun 2026 | Atul Choksey and Amit Choksey re-appointed at the 40th AGM | Over 99.99% votes in favour |
Major Shareholders
| Holder category | % |
|---|---|
Promoters & promoter group | 58.23 |
Foreign portfolio investors (46 FPIs) | 0.69 |
Mutual funds (4 schemes) | 1.28 |
Total institutional | 2.60 |
Public / retail and others | ~39.2 |
Major Shareholders by Rank
| Rank | Holder | Shares (Mn) | Stake (%) |
|---|---|---|---|
| 1 | Abhiraj Choksey (promoter) | 7.42 | 14.3 |
| 2 | Parul Choksey (promoter group) | 7.40 | 14.3 |
| 3 | Atul Choksey (promoter) | 6.88 | 13.3 |
| 4 | Devanshi Jalan (promoter group) | 5.97 | 11.5 |
| 5 | ICICI Prudential AMC | 0.82 | 1.59 |
| 6 | Mita Shah | 0.58 | 1.12 |
| 7 | Farokh Pandole | 0.55 | 1.06 |
| 8 | Investor Education & Protection Fund | 0.54 | 1.03 |
Competitive Landscape
Peer Comparison FY2026
| Dimension | Apcotex | Arlanxeo | Zeon | Synthomer |
|---|---|---|---|---|
Scale | Small (FY2026 revenue INR 14.4 bn ≈ USD 0.17 bn) | Global top-tier synthetic rubber | Large Japanese specialty elastomers | Global latex leader |
Focus | Emulsion polymers (latex + NBR) | Synthetic rubber | Elastomers + specialty materials | Latex + coatings polymers |
Indian position | Sole local NBR, HSR and nitrile latex producer | Importer | Importer | Importer / formerly owned Valia via Omnova |
Cost advantage in India | Freight, duty and service proximity | Scale | Technology | Scale |



